I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Carnevalli, Larissa S
74
results:
Search for persons
X
Format
Online (74)
Mediatypes
Articles (Online) (31)
OpenAccess-fulltext (43)
Sorted by: Relevance
Sorted by: Year
?
1
Author Correction: Combining the AKT inhibitor capivasertib..:
Hopcroft, Lorna
;
Wigmore, Eleanor M.
;
Williamson, Stuart C.
...
npj Breast Cancer. 9 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
2
Combining the AKT inhibitor capivasertib and SERD fulvestra..:
Hopcroft, Lorna
;
Wigmore, Eleanor M.
;
Williamson, Stuart C.
...
npj Breast Cancer. 9 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
3
Author Correction: Combining the AKT inhibitor capivasertib..:
Hopcroft, Lorna
;
Wigmore, Eleanor M.
;
Williamson, Stuart C.
...
npj Breast Cancer. 9 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
4
Genome engineering for estrogen receptor mutations reveals ..:
Harrod, Alison
;
Lai, Chun-Fui
;
Goldsbrough, Isabella
...
Oncogene. 41 (2022) 44 - p. 4905-4915 , 2022
Link:
https://doi.org/10.1038/..
?
5
A preclinical model of peripheral T‐cell lymphoma GATA3 rev..:
Kuczynski, Elizabeth A
;
Morlino, Giulia
;
Peter, Alison
...
EMBO Molecular Medicine. 14 (2022) 6 - p. , 2022
Link:
https://doi.org/10.15252..
?
6
Direct targeting of FOXP3 in Tregs with AZD8701, a novel an..:
Revenko, Alexey
;
Carnevalli, Larissa S
;
Sinclair, Charles
...
Journal for ImmunoTherapy of Cancer. 10 (2022) 4 - p. e003892 , 2022
Link:
https://doi.org/10.1136/..
?
7
Landscapes of cellular phenotypic diversity in breast cance..:
Georgopoulou, Dimitra
;
Callari, Maurizio
;
Rueda, Oscar M.
...
Nature Communications. 12 (2021) 1 - p. , 2021
Link:
https://doi.org/10.1038/..
?
8
Therapeutic Approaches Targeting the Natural Killer-Myeloid..:
Carnevalli, Larissa S.
;
Ghadially, Hormas
;
Barry, Simon T.
Frontiers in Immunology. 12 (2021) - p. , 2021
Link:
https://doi.org/10.3389/..
?
9
A phase 1/2 study of the combination of acalabrutinib and v..:
Collins, Graham P.
;
Clevenger, Tracy N.
;
Burke, Kathleen A.
...
Leukemia & Lymphoma. 62 (2021) 11 - p. 2625-2636 , 2021
Link:
https://doi.org/10.1080/..
?
10
Quantifying cell cycle-dependent drug sensitivities in canc..:
Johnson, Timothy I.
;
Minteer, Christopher J.
;
Kottmann, Daniel
...
EBioMedicine. 68 (2021) - p. 103396 , 2021
Link:
https://doi.org/10.1016/..
?
11
Dissecting the early steps of MLL induced leukaemogenic tra..:
Basilico, Silvia
;
Wang, Xiaonan
;
Kennedy, Alison
...
Nature Communications. 11 (2020) 1 - p. , 2020
Link:
https://doi.org/10.1038/..
?
12
Longitudinal immune characterization of syngeneic tumor mod..:
Taylor, Molly A.
;
Hughes, Adina M.
;
Walton, Josephine
...
Journal for ImmunoTherapy of Cancer. 7 (2019) 1 - p. , 2019
Link:
https://doi.org/10.1186/..
?
13
Functional significance of co-occurring mutations in PIK3CA..:
Avivar-Valderas, Alvaro
;
McEwen, Robert
;
Taheri-Ghahfarokhi, Amir
...
Oncotarget. 9 (2018) 30 - p. 21444-21458 , 2018
Link:
https://doi.org/10.18632..
?
14
Combination of dual mTORC1/2 inhibition and immune-checkpoi..:
Langdon, Sophie
;
Hughes, Adina
;
Taylor, Molly A.
...
OncoImmunology. , 2018
Link:
https://doi.org/10.1080/..
?
15
PI3Kα/δ inhibition promotes anti-tumor immunity through dir..:
Carnevalli, Larissa S.
;
Sinclair, Charles
;
Taylor, Molly A.
...
Journal for ImmunoTherapy of Cancer. 6 (2018) 1 - p. , 2018
Link:
https://doi.org/10.1186/..
1-15